Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Pharmaceutical Design

Volume 14 Issue 5
ISSN: 1381-6128
eISSN: 1873-4286


   All Titles

  Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
  pp.412-421 (10) Authors: N. G. Abraham, P. L. Tsenovoy, J. McClung, G. S. Drummond

Heme oxygenase-1 (HO-1) is central to the regulation of oxidative injury. The role of increased HO-1 expression and Heme oxygenase (HO) activity in mitigating the detrimental side effect of diabetes is examined. A review of the mechanism(s) of action is included. This may lead to the development of pharmacological and genetic approaches to mitigate the clinical complications associated with the progression of diabetes and obesity.

  Keywords: Diabetes, Carbon monoxide, bilirubin, HO-1, Inflamation, TNF, IL-1, adiponectin
  Affiliation: New York Medical College, Director of Gene Therapy, Room 527, Valhalla NY 10595, USA.
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers


  Copyright © 1994 - 2015   Bentham Science Publishers